Oriola Oyj reported impairment charges for the third quarter of 2023. The company recognized an impairment loss of goodwill of approximately EUR 3.3 million relating directly to the transaction. In addition, the company has recognized an impairment loss of goodwill of EUR 18.1 million to the dose dispensing cash generating unit in third quarter of 2023.

This means that the total impairment loss on goodwill amounts to EUR 21.4 million.